On March 1, 2012, the Food and Drug Administration (FDA) celebrated the fifth annual Rare Disease Day by hosting a "FDA Rare Disease Patient Advocacy Day" to engage and educate the rare disease community on regulatory processes related to rare diseases.
This meeting was held to enhance the awareness of the rare disease community as to FDA’s roles and responsibilities in the development of products (drugs, biological products and devices) for the diagnosis, prevention, and/or treatment of rare diseases or conditions.
- For more information about Rare Disease Day, see Rare Diseases Take Spotlight in Annual Event.
- For more information about the History of FDA and Milestones In U.S. Food and Drug Law, see About the FDA
Meeting Evaluation: The FDA values your review of this event. We encourage participants to contact us with your comments at: firstname.lastname@example.org
Video Recording of March 01, 2012 event:
- Plenary Session (8:30am-10:35am)
- Plenary Session (10:55am-12:00pm)
- Keynote Address (1:30pm-2:00pm)
- Senior Townhall (4:30pm-5:00pm)
Recap of the Patient Advocacy Day Meeting:
The FDA Rare Disease Patient Advocacy Day is supported by the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the National Organization for Rare Disorders (NORD), and the Genetic Alliance.